CN1298713C - 5-取代异苯并呋喃的制备方法 - Google Patents

5-取代异苯并呋喃的制备方法 Download PDF

Info

Publication number
CN1298713C
CN1298713C CNB028183231A CN02818323A CN1298713C CN 1298713 C CN1298713 C CN 1298713C CN B028183231 A CNB028183231 A CN B028183231A CN 02818323 A CN02818323 A CN 02818323A CN 1298713 C CN1298713 C CN 1298713C
Authority
CN
China
Prior art keywords
formula
group
citalopram
trityl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028183231A
Other languages
English (en)
Chinese (zh)
Other versions
CN1555370A (zh
Inventor
L·达尔阿斯塔
G·科提斯里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Infosint SA
Original Assignee
Infosint SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infosint SA filed Critical Infosint SA
Publication of CN1555370A publication Critical patent/CN1555370A/zh
Application granted granted Critical
Publication of CN1298713C publication Critical patent/CN1298713C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/34Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNB028183231A 2001-08-02 2002-07-29 5-取代异苯并呋喃的制备方法 Expired - Fee Related CN1298713C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01830517A EP1281707B1 (en) 2001-08-02 2001-08-02 Process for the preparation of 5-subtituted isobenzofurans
EP01830517.7 2001-08-02

Publications (2)

Publication Number Publication Date
CN1555370A CN1555370A (zh) 2004-12-15
CN1298713C true CN1298713C (zh) 2007-02-07

Family

ID=8184643

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028183231A Expired - Fee Related CN1298713C (zh) 2001-08-02 2002-07-29 5-取代异苯并呋喃的制备方法

Country Status (22)

Country Link
US (1) US7166729B2 (enExample)
EP (1) EP1281707B1 (enExample)
JP (1) JP2005501056A (enExample)
KR (1) KR20040043176A (enExample)
CN (1) CN1298713C (enExample)
AR (1) AR036212A1 (enExample)
AT (1) ATE286037T1 (enExample)
AU (1) AU2002325385B2 (enExample)
BG (1) BG108554A (enExample)
BR (1) BR0211858A (enExample)
CA (1) CA2456004A1 (enExample)
DE (1) DE60108105T2 (enExample)
DK (1) DK1281707T3 (enExample)
ES (1) ES2234797T3 (enExample)
HU (1) HUP0401166A3 (enExample)
MX (1) MXPA04001030A (enExample)
PL (1) PL368320A1 (enExample)
PT (1) PT1281707E (enExample)
RO (1) RO122147B1 (enExample)
TW (1) TWI225055B (enExample)
WO (1) WO2003011846A2 (enExample)
ZA (1) ZA200400841B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
WO2004026855A1 (en) * 2002-09-20 2004-04-01 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
GB0601286D0 (en) * 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
EP2227233B1 (en) 2007-11-30 2013-02-13 Newlink Genetics Ido inhibitors
CN106632182A (zh) * 2016-12-07 2017-05-10 万全万特制药(厦门)有限公司 草酸艾司西酞普兰脱甲基杂质的制备方法
DE112019006382T8 (de) * 2018-12-22 2021-12-09 Malladi Drugs And Pharmaceuticals Ltd. NEUES VERFAHREN ZUR HERSTELLUNG VONR-PHENYLACETYLCARBINOL UND β-AMINOALKOHOLEN

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0171943A1 (en) * 1984-08-06 1986-02-19 H. Lundbeck A/S Novel intermediate and method for its preparation
US4943590A (en) * 1988-06-14 1990-07-24 H. Lundbeck A/S Pharmaceutically useful (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydrosobenzofuran-5-carbonitrile and non-toxic acid addition salts thereof
WO1998019513A2 (en) * 1997-07-08 1998-05-14 H. Lundbeck A/S Method for the preparation of citalopram
WO1999030548A2 (en) * 1999-04-14 1999-06-24 H. Lundbeck A/S Method for the preparation of citalopram
WO2001002383A2 (en) * 1999-07-06 2001-01-11 Lundbeck Pharmaceuticals Italy S.P.A. Process for the synthesis of citalopram

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
IT1319686B1 (it) * 2000-12-12 2003-10-23 C D Farmasint S R L Procedimento di preparazione di citalopram.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0171943A1 (en) * 1984-08-06 1986-02-19 H. Lundbeck A/S Novel intermediate and method for its preparation
US4943590A (en) * 1988-06-14 1990-07-24 H. Lundbeck A/S Pharmaceutically useful (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydrosobenzofuran-5-carbonitrile and non-toxic acid addition salts thereof
WO1998019513A2 (en) * 1997-07-08 1998-05-14 H. Lundbeck A/S Method for the preparation of citalopram
WO1999030548A2 (en) * 1999-04-14 1999-06-24 H. Lundbeck A/S Method for the preparation of citalopram
WO2001002383A2 (en) * 1999-07-06 2001-01-11 Lundbeck Pharmaceuticals Italy S.P.A. Process for the synthesis of citalopram

Also Published As

Publication number Publication date
ZA200400841B (en) 2005-02-02
KR20040043176A (ko) 2004-05-22
BR0211858A (pt) 2004-09-21
TWI225055B (en) 2004-12-11
DE60108105D1 (de) 2005-02-03
US7166729B2 (en) 2007-01-23
HUP0401166A3 (en) 2007-05-29
DE60108105T2 (de) 2005-12-08
CN1555370A (zh) 2004-12-15
HK1070357A1 (zh) 2005-06-17
PT1281707E (pt) 2005-04-29
AU2002325385B8 (en) 2003-02-17
ATE286037T1 (de) 2005-01-15
US20040230065A1 (en) 2004-11-18
AR036212A1 (es) 2004-08-18
WO2003011846A2 (en) 2003-02-13
CA2456004A1 (en) 2003-02-13
HUP0401166A2 (hu) 2004-09-28
PL368320A1 (en) 2005-03-21
BG108554A (bg) 2005-03-31
RO122147B1 (ro) 2009-01-30
EP1281707A1 (en) 2003-02-05
WO2003011846A3 (en) 2003-11-27
JP2005501056A (ja) 2005-01-13
EP1281707B1 (en) 2004-12-29
DK1281707T3 (da) 2005-05-02
MXPA04001030A (es) 2004-12-03
AU2002325385B2 (en) 2007-07-05
WO2003011846B1 (en) 2003-12-24
ES2234797T3 (es) 2005-07-01

Similar Documents

Publication Publication Date Title
CN1055466C (zh) 制备1,2-苯并异噻唑-3-酮的方法
JP2014505097A (ja) アジルサルタンメドキソミルの改良製造方法
CN1298713C (zh) 5-取代异苯并呋喃的制备方法
CN1066728C (zh) 生产环氧化物的方法
CN1118783A (zh) 新的吡啶并[3,2-b][1,5]苯并硫代吖庚因的制备方法
EP2809665A1 (en) Process for the preparation of vilazodone or its pharmaceutically acceptable salts
CN1301259A (zh) 用作抗糖尿病剂的α-(1-哌嗪基)乙酰氨基芳烃羧酸衍生物
CN1642936A (zh) 合成手性n-芳基哌嗪的方法
CN1922188A (zh) 氯吡格雷之药学可接受的盐
CN1720228A (zh) 制备利培酮及其中间体的方法
EA003609B1 (ru) Способ получения замещенных 4-фенил-4-цианоциклогексановых кислот
HK1043129A1 (en) Method for the preparation of citalopram
CN1178934C (zh) 苯并呋喃衍生物
CN1313283A (zh) 用于制备一类取代的二噁嗪的中间体
HK1070357B (en) Process for the preparation of 5-substituted isobenzofurans
CN1761668A (zh) 具有抗肿瘤活性的喜树碱的7-亚氨基衍生物
AU2002325385A1 (en) Process for the preparation of 5-substituted isobenzofurans
EP2017271A1 (en) Process for the preparation of escitalopram
CN1326436A (zh) 制备链烯基取代二肟醚衍生物的方法
CN101061121A (zh) 生产苯并[с]菲啶衍生物的方法
CN109824537B (zh) 一种n-(3-乙酰基-2-羟基苯基)乙酰胺的制备方法
CN1690038A (zh) 生产2-苯甲酸基乙醛衍生物的方法
GB2376945A (en) Citalopram preparation
HK1071368A1 (en) Method for the preparation of citalopram
HK1071368B (en) Method for the preparation of citalopram

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1070357

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee